The Mother's House: a new concept in antepartum care
The Mother's House: a new concept in antepartum care
复制标题
DOI：
10.1016/j.ajog.2007.04.045
复制
发表时间：
2007-08-01
影响因子：
9.8
通讯作者：
Roegge, Deborah D.
中科院分区：
文献类型：
--
作者：
Bivins, Harold A., Jr.;McCallum, Olivia J.;Roegge, Deborah D.
目的：高危产前患者通常需要长期且昂贵的住院治疗。母亲之家设施已被用来在医院内安置产前妇女，作为住院管理的替代方案。这项研究考察了该设施的成本效益。研究设计：对 2003 年至 2005 年母亲之家的居住者（n = 111）进行了回顾性图表审查。收集入院、出院和结果数据。然后对 Mother's House 的管理成本与住院患者管理的估计成本进行了比较。结果：使用 Mother's House 在 3 年内节省了 210 万美元的成本。人口统计数据显示，药物筛查呈阳性的患者更有可能在 Mother's House 管理中失败。结论：Mother's House 是一些产前患者住院管理的一种经济有效的替代方案。应修改入院标准以排除药物筛查呈阳性的患者。
OBJECTIVE: High-risk antepartum patients often require long and costly hospitalization. The Mother's House facility has been used to house antepartum women on hospital property as an alternative to inpatient management. This study looked at the cost effectiveness of this facility.STUDY DESIGN: A retrospective chart review on occupants (n = 111) of the Mother's House from 2003-2005 was performed. Admission, discharge, and outcome data were collected. A comparison of the cost of management at the Mother's House with the estimated cost of inpatient management was then performed.RESULTS: A cost savings of $2.1 million was seen over a 3-year period with the use of the Mother's House. Demographic data show that patients with positive drug screens are more likely to fail Mother's House management.CONCLUSION: The Mother's House is a cost effective alternative to inpatient management of some antepartum patients. Admission criteria should be modified to exclude patients with positive drug screens.